Amylyx Pharmaceuticals, Inc. - Common Stock (NQ:AMLX)

14.19 +0.06 (+0.42%)

Streaming Delayed Price Updated: 2:44 PM EST, Feb 18, 2026 Add to My Watchlist

Price and Volume

Volume	229,714
Open	13.99
Bid (Size)	14.16 (800)
Ask (Size)	14.19 (100)
Prev. Close	14.13
Today's Range	13.83 - 14.62
52wk Range	2.600 - 17.49
Shares Outstanding	67,176,067
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million ↗

February 01, 2026

A Co-CEO of a leading neurotherapeutics developer reported significant insider selling amid a year of standout stock performance. But the sale is not what it seems.

Via The Motley Fool

Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S

January 08, 2026

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Performance

YTD	+24.3%	+24.3%
1 Month	-14.3%	-14.3%
3 Month	+1.7%	+1.7%
6 Month	+81.5%	+81.5%
1 Year	+298.6%	+298.6%

More News

This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗

December 09, 2025

Via The Motley Fool

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? ↗

December 09, 2025

Via The Motley Fool

Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets ↗

December 09, 2025

Via The Motley Fool

Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial

December 05, 2025

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance? ↗

December 03, 2025

Via The Motley Fool

This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗

November 17, 2025

Via The Motley Fool

This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗

November 17, 2025

Via The Motley Fool

Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying ↗

November 17, 2025

Via The Motley Fool

This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗

November 17, 2025

Via The Motley Fool

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX

November 13, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX

November 11, 2025

From Rosen Law Firm

Via Business Wire

Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Avantor, Inc. (NYSE: AVTR); Humana Inc. (NYSE: HUM); and Maison Solutions Inc. (NASDAQ: MSS): Grabar Law Office Investigates Claims on Your Behalf

November 06, 2025

From Grabar Law Office

Via GlobeNewswire

Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) Narrows Q3 2025 Loss, Bolsters Cash Runway to 2028 ↗

November 06, 2025

Via Chartmill

Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results

November 06, 2025

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Amylyx Pharmaceuticals to Present at Upcoming Investor Conferences

November 03, 2025

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); and Treace Medical Concepts (NASDAQ: TMCI): Grabar Law Office Investigates Claims on Your Behalf

October 30, 2025

From Grabar Law Office

Via GlobeNewswire

Amylyx Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

October 30, 2025

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Halper Sadeh LLC Encourages Amylyx Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights

October 27, 2025

From Halper Sadeh LLC

Via Business Wire

Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM): Grabar Law Office Investigates Claims on Your Behalf

October 23, 2025

From Grabar Law Office

Via GlobeNewswire

October 20, 2025

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Humana Inc. (NYSE: HUM); Five Below, Inc. (NASDAQ: FIVE); and Hertz Global Holdings, Inc. (NASDAQ: HTZ): Grabar Law Office is Investigating Claims on Your Behalf

October 17, 2025

From Grabar Law Office

Via GlobeNewswire

AMYLYX INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Amylyx Investors to Contact the Firm Regarding Ongoing Investigation into Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders

October 16, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Frequently Asked Questions

Is Amylyx Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Amylyx Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Amylyx Pharmaceuticals, Inc. - Common Stock trade on?

Amylyx Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Amylyx Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Amylyx Pharmaceuticals, Inc. - Common Stock is AMLX on the Nasdaq Stock Market

What is the current price of Amylyx Pharmaceuticals, Inc. - Common Stock?

The current price of Amylyx Pharmaceuticals, Inc. - Common Stock is 14.19

When was Amylyx Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Amylyx Pharmaceuticals, Inc. - Common Stock was at 02/18/26 02:44 PM ET

What is the market capitalization of Amylyx Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Amylyx Pharmaceuticals, Inc. - Common Stock is 953.23M

How many shares of Amylyx Pharmaceuticals, Inc. - Common Stock are outstanding?

Amylyx Pharmaceuticals, Inc. - Common Stock has 953M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.